Inpatient and Outpatient Orderable

Estradiol Ultrasensitive Build info

Synonyms

  • ESTRADIOL ULTRASENSITIVE
  • ESTRAULTRA
  • LAB10870

Procedure Name

ESTRADIOL ULTRASENSITIVE

Procedure Master Number

LAB10870

Procedure ID

114244

Clinical Info

Recommended for clinical situations in which increased sensitivity of E2 levels is appropriate, including postmenopausal women, men, and children and adolescents

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Red Top Tube

Collection Instructions

Container/Tube:  Red top tube or Gold top Tube
Specimen: 1.0  mL serum (0.6 mL min)
Transport Temperature: Refrigerated
Stability: 14 Days Room Temperature, Refrigerated or Frozen
 

Specimen Volume

1.0  mL serum (0.6 mL min)

Transport Instructions

Refrigerated

Specimen Stability

14 Days Room Temperature, Refrigerated or Frozen
 

Methodology

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)
 
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.

Days Performed

Performing Laboratory

LabCorp

CPT

82670
 
LOINC Code: 35384-7

PDM

 5960055

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ESTRADIOL ULTRASENSITIVE ESTRADIOLUS ESTRADIOL ULTRASENSITIVE Estradiol, Sensitive
ESTRADIOL ULTRA RESULTS RECEIVED ESTRDIOULTRR ESTRADIOL ULTRA RESULTS RECEIVED Estradiol Ultra Results Received

Result Interpretation

Newborn: Levels are markedly elevated at birth and fall rapidly during the first week to prepubertal levels <15.0 pg/mL.
1 to 6 months: Male: Levels increase to 10.0−32.0 pg/mL between 30 and 60 days, then decline to prepubertal levels <15.0 pg/mL by six months.
1 to 11 months: Female: Levels increase to 5.0−50.0 pg/mL between 30 and 60 days, then decline to prepubertal levels <15.0 pg/mL by the first year.
Prepubertal children:
• Male (6 months to 10 years): <15.0
• Female (1 to 9 years): <15.0
Puberty: See table.
Tanner Stage
Male
1
Age (y)
 <9.8
Range (pg/mL)
 5.0−11.0
Mean (pg/mL)
 8.0
2
Age (y)
 9.8−14.5
Range (pg/mL)
 5.0−16.0
Mean (pg/mL)
 11.0
3
Age (y)
 10.7−15.4
Range (pg/mL)
 5.0−25.0
Mean (pg/mL)
 16.0
4
Age (y)
 11.8−16.2
Range (pg/mL)
 10.0−36.0
Mean (pg/mL)
 22.0
5
Age (y)
 12.8−17.3
Range (pg/mL)
 10.0−36.0
Mean (pg/mL)
 21.0
Female
1
Age (y)
 <9.2
Range (pg/mL)
 5.0−20.0
Mean (pg/mL)
 8.0
2
Age (y)
 9.2−13.7
Range (pg/mL)
 10.0−24.0
Mean (pg/mL)
 16.0
3
Age (y)
 10.0−14.4
Range (pg/mL)
 7.0−60.0
Mean (pg/mL)
 25.0
4
Age (y)
 10.7−15.6
Range (pg/mL)
 21.0−85.0
Mean (pg/mL)
 47.0
5
Age (y)
 11.8−18.6
Range (pg/mL)
 34.0−170.0
Mean (pg/mL)
 110.0
Adults
Age (y)
 Range (pg/mL)
Male
Age (y)
 8.0−35.0
Female
Follicular
Age (y)
 30.0−100.0
Luteal
Age (y)
 70.0−300.0
Postmenopausal
Age (y)
 <15.0
Tanner Stage
 Age (y)
 Range (pg/mL)
 Mean (pg/mL)
Male
1
 <9.8
 5.0−11.0
 8.0
2
 9.8−14.5
 5.0−16.0
 11.0
3
 10.7−15.4
 5.0−25.0
 16.0
4
 11.8−16.2
 10.0−36.0
 22.0
5
 12.8−17.3
 10.0−36.0
 21.0
Female
1
 <9.2
 5.0−20.0
 8.0
2
 9.2−13.7
 10.0−24.0
 16.0
3
 10.0−14.4
 7.0−60.0
 25.0
4
 10.7−15.6
 21.0−85.0
 47.0
5
 11.8−18.6
 34.0−170.0
 110.0
Adults
 Range (pg/mL)
Male
 8.0−35.0
Female
Follicular
 30.0−100.0
Luteal
 70.0−300.0
Postmenopausal
 <15.0

Forms
edit